NovaBridge Biosciences annual stock-based compensation
2018
2019
2020
2021
2022
2023
2024
2025
NovaBridge Biosciences Stock-Based Compensation Growth & History (NBP)
NovaBridge Biosciences's stock-based compensation was $6.0M for fiscal 2025.
View full NovaBridge Biosciences company overviewNovaBridge Biosciences annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.0M | $7.9M | — |
| 2024 | 2024-12-31 | −$1.9M | −$12.2M | — |
| 2023 | 2023-12-31 | $10.2M | −$2.9M | −22.13% |
| 2022 | 2022-12-31 | $13.1M | −$82.4M | −86.23% |
| 2021 | 2021-12-31 | $95.5M | $19.9M | +26.28% |
| 2020 | 2020-12-31 | $75.6M | $22.9M | +43.50% |
| 2019 | 2019-12-31 | $52.7M | $52.7M | — |
| 2018 | 2018-12-31 | $0 | — | — |
NovaBridge Biosciences quarterly stock-based compensation
Q3.24
Q4.24
Q3.25
Q4.25
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $3.9M | $3.1M | +378.76% |
| Q3 2025 | 2025-09-30 | $1.5M | $1.1M | +358.18% |
| Q4 2024 | 2024-12-31 | $824,000 | — | — |
| Q3 2024 | 2024-09-30 | $318,000 | — | — |
NovaBridge Biosciences stock-based compensation trends
Over the last five fiscal years, NovaBridge Biosciences's stock-based compensation decreased from $75.6M to $6.0M, a change of −$69.7M. The latest reported quarter, Q4 2025, shows $3.9M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NovaBridge Biosciences source filings ↗